Skip to content

Welcome to Discover Pharma! Today is : November 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

T-cell immunotherapy

  • Research & Development,Therapeutic Areas

    Aravax reports positive Phase 2 results for peanut allergy immunotherapy

    Aravax’s PVX108 immunotherapy met its primary endpoint in a Phase [...]

    November 13, 2026
  • Advanced Therapies,Clinical & Regulatory

    AstriVax begins clinical trial of targeted T-cell immunotherapy for hepatitis B

    AstriVax Therapeutics has initiated a phase 1 clinical trial of [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • PharmaForceIQ launches AI visibility tool for biopharma companies
    Categories: Biotech & Pharma Business, Digital & Data
  • SiOxMed partners with Gifthealth to offer SiOxC skin cream directly to patients
    Categories: Biotech & Pharma Business, Drug Delivery & Formulation, Therapeutic Areas
  • Mineralys reports sustained blood pressure reduction with lorundrostat at week 48
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top